Danno Pharmaceuticals' first day oversubscribed by 21 times

robot
Abstract generation in progress

May 15, 2026

Dano Pharmaceutical’s first-day oversubscription is 21 times

================================================

The unprofitable biotech company Dano Pharmaceutical (06872) launched its IPO yesterday, planning to raise approximately HKD 627 million. The offering price is HKD 75.7 per share, with a lot size of 50 shares, and an entry fee of HKD 3,823.17.
Dano Pharmaceutical is offering 8.2806 million shares (accounting for 16% of the enlarged share capital), with about 10% allocated to Hong Kong, and no mandatory clawback; the shares will close trading next Tuesday (19th), with an expected listing on May 22, and the trading has a 15% offering volume limit…

(Excerpt)

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned